A small US study involving toddlers diagnosed with autism, some as as young as 18 months old, showed that intensive early intervention delivered by trained specialists and parents was very effective and improved IQ, social interaction and language ability.
More: continued here
Filed under: Autism on November 30th, 2009 | No Comments »
Darwin suggested that the action of natural selection can produce new species, but 150 years after the publication of his famous book, ‘On the Origin of Species’, debate still continues on the mechanisms of speciation. New research finds sexual selection to greatly enlarge the scope for adaptive speciation by triggering a positive feedback between mate […]
Filed under: Biology on November 30th, 2009 | No Comments »
Southern Illinois University researchers determined Medicare beneficiaries living in rural areas were 27% more likely than urban recipients to have total knee or hip replacement surgeries. Researchers found women were more likely than men to undergo total joint replacement surgeries. Differences in elective joint surgeries between white individuals and minorities in both rural and urban […]
Filed under: Arthritis on November 30th, 2009 | No Comments »
Cutting-edge technologies are about to enter the marketplace, thanks to a new partnership between Gestion Univalor, Limited Partnership (Univalor) and Cognitive Sensing Inc. (CSI), a privately owned technology company based in Montreal.
More: continued here
Filed under: Alzheimer's / Dementia News XML/RSS Feed on November 30th, 2009 | No Comments »
Limitations in therapy induced by adverse effects due to unselective drug availability and therefore the use of potentially too high doses are a common problem. One prominent example for this dilemma are inflammatory diseases. The therapeutic drawback can be overcome using nanocarrier-based drug targeting strategies which improve the selective delivery […]
Filed under: Arthritis on November 30th, 2009 | No Comments »
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced that the European Medicines Agency (”EMEA”) has determined that the Marketing Authorization Application (”MAA”) for omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia (CML) patients who have failed treatment with imatinib and who have developed the Bcr-Abl T315I mutation is valid.
More: continued here
Filed under: Blood on November 30th, 2009 | No Comments »
Bacteria don’t have easy lives. In addition to mammalian immune systems that besiege the bugs, they have natural enemies called bacteriophages, viruses that kill half the bacteria on Earth every two days.
More: continued here
Filed under: Biology on November 30th, 2009 | No Comments »
A novel early intervention program for very young children with autism - some as young as 18 months - is effective for improving IQ, language ability, and social interaction, a comprehensive new study has found. “This is the first controlled study of an intensive early intervention that is appropriate for children with […]
Filed under: Autism on November 30th, 2009 | No Comments »
When cells are confronted with an invading virus or bacteria or exposed to an irritating chemical, they protect themselves by going off their DNA recipe and inserting the wrong amino acid into new proteins to defend them against damage, scientists have discovered.
More: continued here
Filed under: Biology on November 30th, 2009 | No Comments »
Two Kent State University assistant professors recently received funding from the National Science Foundation (NSF) to continue research beneficial to understanding the environment. The three grants total $890,000. Christopher Blackwood, assistant professor in the Department of Biological Sciences, was awarded grants to support two separate research projects.
More: continued here
Filed under: Biology on November 30th, 2009 | No Comments »